Resumen
Microbiome is being intensively studied in the context of many diseases, as well as health maintenance. Proper understanding of microbiota alterations in gastrointestinal cancers on the taxonomic and functional level (i.e., metabolic pathways and metabolites) creates good basics for further therapy and biomarker development.